Holen Sie sich die Stockscreener-App
3.30
0.61%
0.02
Schlusskurs vom Vortag:
$3.28
Offen:
$3.27
24-Stunden-Volumen:
696.40K
Relative Volume:
1.31
Marktkapitalisierung:
$151.73M
Einnahmen:
$84.32M
Nettoeinkommen (Verlust:
$-3.16M
KGV:
-66.00
EPS:
-0.05
Netto-Cashflow:
$-4.50M
1W Leistung:
+0.92%
1M Leistung:
+2.80%
6M Leistung:
+114.29%
1J Leistung:
+166.13%
1-Tages-Spanne:
$3.26
$3.31
1-Wochen-Bereich:
$3.26
$3.31
52-Wochen-Spanne:
$1.12
$3.31
Theratechnologies Inc Stock (THTX) Company Profile
Firmenname
Theratechnologies Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie THTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
3.30 | 150.35M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Aktie (THTX) Neueste Nachrichten
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 31.4% in August - MarketBeat
Theratechnologies shareholders approve acquisition by Future Pak affiliate - Investing.com India
Theratechnologies shareholders approve acquisition by Future Pak affiliate By Investing.com - Investing.com South Africa
Theratechnologies Shareholders Approve Acquisition by Future Pak Affiliate - TipRanks
Theratechnologies (THTX) Shareholders Approve Key Arrangement with CB Biotechnology - GuruFocus
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewswire
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - Benzinga
97.4% Shareholder Approval: Theratechnologies Set for Future Pak Acquisition in Biotech Deal - Stock Titan
Does Theratechnologies Inc. have a sustainable dividendJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Lancaster City Council
Is This a Bottoming Phase for Theratechnologies Inc.2025 Trading Recap & Free High Return Stock Watch Alerts - beatles.ru
Theratechnologies Launches EGRIFTA WR™ for HIV-Related Lipodystrophy - MSN
How hedge fund analytics apply to Theratechnologies Inc. stockJuly 2025 WrapUp & Long-Term Safe Return Strategies - Newser
Theratechnologies Gains Support for Future Pak Acquisition - MSN
What’s the outlook for Theratechnologies Inc.’s sectorJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - خودرو بانک
Nantahala Capital Management LLC Decreases Holdings in Theratechnologies Inc. $THTX - MarketBeat
Will Theratechnologies Inc. outperform the market2025 Price Targets & Free Long-Term Investment Growth Plans - Newser
Theratechnologies Inc. stock chart pattern explainedJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
Theratechnologies Announces Availability of EGRIFTA WR™ - GlobeNewswire
Aug PostEarnings: Will Theratechnologies Inc. benefit from geopolitical trendsJobs Report & Weekly High Return Opportunities - خودرو بانک
Theratechnologies Inc. - Baystreet.ca
Stocks In Play: Theratechnologies Inc. - Barchart.com
Theratechnologies Launches New Tesamorelin Formulation in US After FDA Approval - MarketScreener
Will Theratechnologies Inc. bounce back from current supportJuly 2025 Pullbacks & Free Safe Capital Growth Stock Tips - Newser
Theratechnologies (THTX) Launches New EGRIFTA WR Formulation for HIV Patients - GuruFocus
Applying Elliott Wave Theory to Theratechnologies Inc.Recession Risk & Safe Entry Point Identification - Newser
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy - The Manila Times
About Us - FinancialContent
Advanced analytics toolkit walkthrough for Theratechnologies Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Theratechnologies Inc. recovery potential after sell off2025 Key Lessons & Weekly Top Stock Performers List - Newser
Will Theratechnologies Inc. see short term momentumQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Theratechnologies Inc. stock daily chart insights2025 Market WrapUp & Stepwise Trade Signal Guides - Newser
What the charts say about Theratechnologies Inc. today2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Will Theratechnologies Inc. outperform small cap indexesJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Analyzing recovery setups for Theratechnologies Inc. investors2025 Earnings Impact & Reliable Trade Execution Plans - Newser
Is Theratechnologies Inc. exposed to currency risks2025 Biggest Moves & Community Shared Stock Ideas - خودرو بانک
What are Theratechnologies Inc.’s growth levers2025 Pullback Review & Fast Entry Momentum Trade Alerts - خودرو بانک
Real time social sentiment graph for Theratechnologies Inc.2025 Market Overview & Low Risk Growth Stock Ideas - Newser
Will Theratechnologies Inc. rebound enough to break even2025 Key Highlights & High Conviction Investment Ideas - Newser
Published on: 2025-09-03 23:17:32 - Newser
Regression analysis insights on Theratechnologies Inc. performance2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Statistical indicators supporting Theratechnologies Inc.’s strengthJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Will Theratechnologies Inc. benefit from geopolitical trendsJuly 2025 Recap & Low Risk High Win Rate Picks - خودرو بانک
Can Theratechnologies Inc. sustain its profitabilityJuly 2025 Final Week & Growth Focused Stock Pick Reports - خودرو بانک
Using RSI to spot recovery in Theratechnologies Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
What earnings revisions data tells us about Theratechnologies Inc.Quarterly Trade Review & Safe Entry Point Identification - Newser
Signal strength of Theratechnologies Inc. stock in tech scannersWeekly Volume Report & Free Community Consensus Stock Picks - Newser
Real Time Data Flags Unusual Activity in Theratechnologies Inc.GDP Growth & Risk Managed Investment Strategies - beatles.ru
Finanzdaten der Theratechnologies Inc-Aktie (THTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):